Hemp CBD Stock Jumps on Sales Approval

EastWest Bioscience (TSXV:EAST), a hemp CBD stock, moved sharply higher after receiving approval to sell its CBD products in Kentucky

Sean Mason | April 10, 2019 | SmallCapPower

A TSX Venture Exchange go ahead sparked speculation in a hemp CBD stock Wednesday. Here’s some small stocks making big moves on Wednesday, April 10, 2019 (as of 4 pm EST):

EastWest Bioscience (TSXV:EAST), a hemp CBD stock, climbed 50% to $0.15 on Wednesday after announcing that the TSX Venture Exchange gave the Company its approval to sell EastWest’s products containing CBD in Kentucky.

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here   

As well, shares of Helius Medical Technologies, Inc. (TSX:HSM) plunged 66% to $2.84 as the neurotech company said the U.S. Food and Drug Administration (FDA) has declined the Company’s request for De Novo classification and 510(k) clearance of the Portable Neuromodulation Stimulator device.

Win Big With Our Small Cap Picks

 

Sirona Biochem Corp. (TSXV:SBM), meanwhile, reported results of its clinical trial conducted in North Carolina, in which Sirona’s TFC-1067 demonstrates “superiority to the gold standard,” hydroquinone, for the treatment of dyschromia (hyperpigmentation), or “dark spots” of the skin. Sirona Biochem stock popped 56% to $0.25 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: